# Rocket Pharmaceuticals, Inc.: Form 8-K, filed Apr 7, 2025

- Company: [Rocket Pharmaceuticals, Inc.](/companies/rckt.md) (CIK 1281895)
- Form: 8-K
- Filed: 2025-04-07
- Accepted by EDGAR: Apr 7, 2025, 17:24 ET
- Period: 2025-04-07
- Accession: 0001140361-25-012621
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1281895/000114036125012621/ef20047021_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1281895/000114036125012621/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1281895/000114036125012621/ef20047021_8k.htm

Filed Apr 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-012621. Last ingested by Listed: Nov 14, 2026, 20:48 ET. No prices; not investment advice.
